Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.67 is 39% above its 5-year average of -1.10, near the high end of its 5-year range (-1.43–-0.67).
As of the fiscal period ended Wednesday, December 31, 2025. 19.28% above its 12-month average of -0.83.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.18.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.67
EARNINGS PER SHARE (EPS) AVG TTM
-0.83
EARNINGS PER SHARE (EPS) AVG 3Y
-1.06
EARNINGS PER SHARE (EPS) AVG 5Y
-1.10
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+19.28%
CURRENT VS 3Y AVG
+36.94%
CURRENT VS 5Y AVG
+39.27%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Sera Prognostics, Inc.
Market Cap
$77.15M
Earnings Per Share (EPS)
-0.67
TTM Avg
-0.83
3Y Avg
-1.06
5Y Avg
-1.10
Market Cap
$77.30M
Earnings Per Share (EPS)
-0.48
TTM Avg
-0.32
3Y Avg
-0.23
5Y Avg
-0.23
Market Cap
$77.49M
Earnings Per Share (EPS)
-4.09
TTM Avg
-21.16
3Y Avg
-36.34
5Y Avg
-37.75
Market Cap
$76.24M
Earnings Per Share (EPS)
-2.22
TTM Avg
-3.23
3Y Avg
-3.23
5Y Avg
-3.23
Market Cap
$78.07M
Earnings Per Share (EPS)
-1.17
TTM Avg
-2.88
3Y Avg
-6.48
5Y Avg
-4.74
Market Cap
$76.45M
Earnings Per Share (EPS)
-0.22
TTM Avg
-0.15
3Y Avg
-0.19
5Y Avg
-0.88
Market Cap
$78.44M
Earnings Per Share (EPS)
-0.11
TTM Avg
-3.20
3Y Avg
-6.52
5Y Avg
-6.93
Market Cap
$74.97M
Earnings Per Share (EPS)
-1.15
TTM Avg
-1.39
3Y Avg
-1.49
5Y Avg
-1.37
Market Cap
$79.61M
Earnings Per Share (EPS)
-1.88
TTM Avg
-2.06
3Y Avg
-2.07
5Y Avg
-1.66
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sera Prognostics, Inc. (SERA) | $77.15M | -0.67 | -0.83 | -1.06 | -1.10 |
| Citius Oncology, Inc. (CTOR)vs › | $77.30M | -0.48 | -0.32 | -0.23 | -0.23 |
| Outset Medical, Inc. (OM)vs › | $77.49M | -4.09 | -21.16 | -36.34 | -37.75 |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $76.24M | -2.22 | -3.23 | -3.23 | -3.23 |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | -1.17 | -2.88 | -6.48 | -4.74 |
| SkinHealth Systems Inc. (SKIN)vs › | $76.45M | -0.22 | -0.15 | -0.19 | -0.88 |
| vTv Therapeutics Inc. (VTVT)vs › | $78.44M | -0.11 | -3.20 | -6.52 | -6.93 |
| Pulmonx Corporation (LUNG)vs › | $74.97M | -1.15 | -1.39 | -1.49 | -1.37 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.61M | -1.88 | -2.06 | -2.07 | -1.66 |
| Hyperfine, Inc. (HYPR)vs › | $73.73M | -0.38 | -0.49 | -0.66 | -0.75 |
Trailing EPS (TTM)
$-0.67
Forward EPS (Est.)
$-0.66
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.67 |
| 2024-12-31 | -0.99 |
| 2023-12-31 | -1.16 |
| 2022-12-31 | -1.43 |
| 2021-12-31 | -1.18 |
| 2020-12-31 | -1.19 |
| 2019-12-31 | -1.13 |
